Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Relapsed extranodal NK/T-cell lymphoma in the mandible, Nasal Type: a case report and review of the literatures

  • Park, Young-Wook (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Park, Yong-Tae (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Choi, Kyo-Hee (Department of Dentistry, College of Medicine, Hallym University) ;
  • Kim, Seong-Gon (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University)
  • ;
  • ;
  • ;
  • 김성곤 (강릉원주대학교 치과대학 구강악안면외과학교실)
  • Received : 2011.04.20
  • Accepted : 2011.07.26
  • Published : 2011.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Extranodal NK/T-cell lymphoma (NTCL), nasal type is rare and highly fatal malignant neoplasm. Early diagnosis and establishing treatment plan are very difficult. Furthermore, NTCL in the mandible is an extremely rare condition. The clinical significance of presented case is the very rare location of NTCL. To the best of author's knowledge, this is the first reported case of NTCL of the mandible in the literature.

Keywords

References

  1. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612-8. https://doi.org/10.1200/JCO.2005.04.1384
  2. Nakamura S, Suchi T, Koshikawa T, Kitoh K, Koike K, Komatsu H, et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284-96. https://doi.org/10.1097/00000478-199503000-00006
  3. Jaffe ES, Lipford EH, Margolick JB, Longo DL, Fauci AS. Lymphomatoid granulomatosis and angiocentric lymphoma: a spectrum of post-thymic T-cell proliferations. Semin Respir Med 1989;10:167-72. https://doi.org/10.1055/s-2007-1006166
  4. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT. Fatal infectious mononucleosis and virus-associated hemo phagocytic syndrome. Arch Pathol Lab Med 1987;111:530-5.
  5. Pileri SA, Montanari M, Falini B, Poggi S, Sabattini E, Baglioni P, et al. Malignant lymphoma involving the mandible. Clinical, morphologic, and immunohistochemical study of 17 cases. Am J Surg Pathol 1990;14:652-9. https://doi.org/10.1097/00000478-199007000-00006
  6. Mafune KI, Tanaka Y, Suda Y, Izumo T. Outcome of patients with non-Hodgkin's lymphoma of the stomach after gastrectomy: clinicopathologic study and reclassification according to the revised European-American lymphoma classification. Gastric Cancer 2001;4:137-43. https://doi.org/10.1007/PL00011736
  7. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
  8. Chorianopoulos D, Samitas K, Vittorakis S, Kiriazi V, Rondoyianni D, Tsaousis G, et al.. Extranodal natural killer/Tcell lymphoma, nasal-type. Skinmed 2010;8:56-8.
  9. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005;19:2186-94. https://doi.org/10.1038/sj.leu.2403955
  10. Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 2007;139:532-44. https://doi.org/10.1111/j.1365-2141.2007.06835.x
  11. Au WY, Pang A, Choy C, Chim CS, Kwong YL. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004;104:243-9. https://doi.org/10.1182/blood-2003-12-4197
  12. Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009;113:3931-7. https://doi.org/10.1182/blood-2008-10-185256
  13. Wong KF, Chan JK, Ng CS, Lee KC, Tsang WY, Cheung MM. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 1992;23:798-804. https://doi.org/10.1016/0046-8177(92)90350-C
  14. Sakata K, Hareyama M, Ohuchi A, Sido M, Nagakura H, Morita K, et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol 1997;36:307-11. https://doi.org/10.3109/02841869709001268
  15. Kim GE, Lee SW, Chang SK, Park HC, Pyo HR, Kim JH, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 2001;61:261-9. https://doi.org/10.1016/S0167-8140(01)00428-5
  16. Kim GE, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000;18:54-63. https://doi.org/10.1200/JCO.2000.18.1.54
  17. Lee KW, Yun T, Kim DW, Im SA, Kim TY, Yoon SS, et al. First-line ifosfamide, methotrexate, etoposide, and prednisolone chemotherapy +/- radiotherapy in active stage I/II extranodal NK/T-cell lymphoma. Leuk Lymphoma 2006;47:1274-82. https://doi.org/10.1080/10428190600562823
  18. Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016-20. https://doi.org/10.1111/j.1349-7006.2008.00768.x
  19. Kim BS, Kim DW, Im SA, Kim CW, Kim TY, Yoon SS, et al. Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Ann Oncol 2009;20:121-8.